BCL2 and HIV infectious disease: As HIV-1 infected subjects are known to express lower levels of Bcl-2 [41], decreased viability as a result of inhibition of Bcl-2 expression may be a potential mechanism of Jak inhibitors on blocking viral persistence along with HIV infection in CD4 cells from viremic donors.